About Research Contact Headache Clinic Patient Information
Consultant Neurologist

Dr Seán O'Sullivan

MB BCh BAO, BMedSc, MRCPI, PhD

Dr Seán O'Sullivan
At a Glance
SpecialtyNeurology
Sub-spec.Parkinson's Disease & Headache
HospitalBon Secours Hospital, Cork
ClinicThe Cork Clinic, Western Road
QualsMB BCh BAO, BMedSc, MRCPI, PhD
IMC No.58739

Consultant Neurologist at Bon Secours Hospital, Cork, with specialist interests in Headache, Parkinson's Disease, and Movement Disorders. Private outpatient consultations at The Cork Clinic, Western Road, Cork.

Dr Seán O'Sullivan is a Consultant Neurologist at Bon Secours Hospital, Cork, with private rooms for outpatient consultations at The Cork Clinic, Western Road, Cork. He completed his undergraduate training at University College Cork, attaining an honours degree MB BCh, BAO and BMedSci.

He subsequently gained a Certificate of General Professional Training from the Royal College of Physicians of Ireland, before entering neurology specialist training at the same college. He undertook a fellowship at the National Hospital for Neurology and Neurosurgery, Queen Square London and completed his specialist neurology training there and at the Royal London Hospital. He has been on the Neurology Specialist Register of the Irish Medical Council since 2009.

Dr O'Sullivan was appointed Consultant Neurologist at St George's Hospital NHS Trust, London and at Frimley Park Hospital NHS Foundation Trust in 2010, before returning as a Consultant Neurologist at Cork University Hospital in 2011 and transferring to Bon Secours Hospital Cork in 2017.

Dr O'Sullivan is only accepting new patient referrals with the following symptoms or suspected diagnoses: headache (including the provision of greater occipital nerve block injections, botulinum toxin injections and anti-CGRP medications in his dedicated Headache Clinic); and Parkinson's disease, tremor, dystonia and other movement disorders.

Dr O'Sullivan completed a PhD in clinical neurology in 2010 from University College London. He has published over 130 peer-reviewed papers, numerous other publications, and is the author of four book chapters. Visit his Research publication list to see more.

Prizes, Awards & Honours

1995
Entrance Scholarship
University College Cork, Ireland
1996
College Scholar
University College Cork, Ireland
2008
Charles Symonds Prize — Best Research Platform Presentation
Association of British Neurologists Annual Meeting
2009
MDS Junior Award — Winning Paper
International Congress of Parkinson's Disease and Movement Disorders
2014–15
Faculty Member
International Congress of Parkinson's Disease and Movement Disorders Annual Meetings

Education & Training

2001
MB BCh BAO, BMedSc
University College Cork
2009
Certificate of Completion of Higher Specialist Training in Neurology
Royal College of Physicians of Ireland
2010
PhD in Clinical Neurology
University College London
2010
Consultant Neurologist
St George's Hospital NHS Trust & Frimley Park Hospital NHS Foundation Trust, London
2011
Consultant Neurologist
Cork University Hospital
2017–
Consultant Neurologist
Bon Secours Hospital, Cork

Professional Memberships

Member, Royal College of Physicians of Ireland Member, American Academy of Neurology Member, International Parkinson and Movement Disorders Society Member, International Headache Society Member, The World Federation of Neurology Member, Irish Neurological Association Co-founder, UCC Parkinson's Disease Research Cluster (PDRC)

Dr O'Sullivan completed a PhD in clinical neurology in 2010 from University College London. He has published over 130 peer-reviewed papers in high quality medical journals, and is the author of four book chapters.

His areas of publication are from across the spectrum of neurological disorders including Parkinson's Disease, Movement Disorders, Epilepsy, Multiple Sclerosis, Stroke, Headache, Neuromuscular Disorders, Peripheral Neuropathy, Spinal Cord diseases, Neuro-genetics, Neuro-Infectious Disease, Neuropathic pain, Autonomic disorders, Sleep disorders, Behavioural Neurology, Neuro-ophthalmology, Neuro-oncology, Neuro-Urology and Dementia.

All published research is listed below in reverse chronological order. Each entry links directly to the PubMed record or original journal article. The full publication list is also available on Google Scholar and PubMed.

Nocturnal Use of Add-On Medications for Parkinson's Disease (PD): Post Hoc Analysis of the COSMOS Study
Gurevich T, O'Sullivan S, Parra J, O'Meara M, Zamudio J, Fasano A
Movement Disorders · 2024 Parkinson's Disease
Management of impulse control and related disorders in Parkinson's disease: an expert consensus
Debove I, Paschen S, Amstutz D, Cardoso F, Corvol JC, Fung VSC, O'Sullivan S et al
Movement Disorders 39(2):235–248 · 2024 Parkinson's Disease
Inter-rater reliability of hand motor function assessment in Parkinson's disease: Impact of clinician training
Kenny L, Azizi Z, Moore K, Alcock M, Heywood S, Jonsson A, McGrath K, O'Sullivan S et al
Clinical Parkinsonism & Related Disorders 11:100278 · 2024 Parkinson's Disease
A subtle presentation of a treatable cause of predominant hemidystonia with minimal ataxia
Wrigley SM, O'Sullivan SS, Ryan AM
Parkinsonism & Related Disorders 107 · 2023 Movement Disorders
Predictors of Motor Symptom Response with Levodopa-Carbidopa Intestinal Gel in Advanced PD: COSMOS Post Hoc Analysis
Fasano A, O'Sullivan S, Johansson A, Parra J, Saad A, Bergmann L et al
European Journal of Neurology 29:175 · 2022 Parkinson's Disease
Neuropsychiatric features of punding and hobbyism in Parkinson's disease
Barbosa P, O'Sullivan SS, Joyce E, Lees AJ, Warner TT, Djamshidian A
Movement Disorders Clinical Practice 9(1):82–86 · 2022 Parkinson's Disease
Neurology patient engagement with online health-related resources
Murphy OC, Suhaimi SS, O'Sullivan SS
Journal of the Neurological Sciences 420 · 2021 Neurology
The 'round the houses' sign and 'zig-zag' sign in progressive supranuclear palsy and other conditions
Fearon C, Field R, Donlon E, Murphy OC, Cronin S, Buckley C, Williams L, O'Sullivan S et al
Parkinsonism & Related Disorders 81:94–95 · 2020 Movement Disorders
Ataxia with Vitamin E Deficiency: Widening the Phenotypic Spectrum
Wrigley S, O'Sullivan S, Ryan A
Neurology 94(15 Suppl):2197 · 2020 Neurology
The long-term outcome of impulsive compulsive behaviours in Parkinson's disease
Barbosa PM, Djamshidian A, O'Sullivan SS, de Pablo-Fernandez E et al
Journal of Neurology Neurosurgery & Psychiatry 90(11):1288–1289 · 2019 Parkinson's Disease
Scales to assess impulsive and compulsive behaviors in Parkinson's disease: critique and recommendations
Evans AH, Okai D, Weintraub D, Lim SY, O'Sullivan SS, Voon V, Krack P et al
Movement Disorders 34(6):791–798 · 2019 Parkinson's Disease
Compulsive sexual behaviour in Parkinson's disease is associated with higher doses of levodopa
Barbosa PM, Grippe T, Lees AJ, O'Sullivan S, Djamshidian A, Warner TT
Journal of Neurology Neurosurgery & Psychiatry 89(10):1121–1123 · 2018 Parkinson's Disease
The utility of dopamine transporter scans for diagnosing Parkinsonian disorders
Crotty GF, O'Corragain OA, Bogue CO, Crotty JM, O'Sullivan SS
Irish Medical Organisation · 2018 Parkinson's Disease
Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease
Robak LA, Jansen IE, Van Rooij J, Uitterlinden AG, Kraaij R, Jankovic J, O'Sullivan SS et al
Brain 140(12):3191–3203 · 2017 Parkinson's Disease
Palliative care for Parkinson's disease: Patient and carer's perspectives explored through qualitative interview
Fox S, Cashell A, Kernohan WG, Lynch M, McGlade C, O'Brien T, O'Sullivan SS et al
Palliative Medicine 31(7):634–641 · 2017 Neurology
Teenage onset head tremor due to novel mutation in GNAL gene
O'Connor A, Buckley M, O'Sullivan SS
Movement Disorders Clinical Practice 4(6):903 · 2017 Movement Disorders
Phenomenology and epidemiology of impulsive-compulsive behaviours in Parkinson's disease, atypical Parkinsonian disorders and non-Parkinsonian populations
Maloney EM, Djamshidian A, O'Sullivan SS
Journal of the Neurological Sciences 374:47–52 · 2017 Parkinson's Disease
Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencing
Jansen IE, Ye H, Heetveld S, Lechler MC, Michels H, Seinstra RI, Lubbe SJ, O'Sullivan SS et al
Genome Biology 18(1):22 · 2017 Parkinson's Disease
A genome-wide association study in multiple system atrophy
Sailer A, Scholz SW, Nalls MA, Schulte C, Federoff M, Price TR, Lees A, O'Sullivan SS et al
Neurology 87(15):1591–1598 · 2016 Neurology
Augmentation and impulsivity in restless legs syndrome patients: A complex interaction
O'Sullivan SS, Poyares D
Neurology 87(1):15–16 · 2016 Neurology
Jumping to conclusions in untreated patients with Parkinson's disease
de Rezende Costa FH, Averbeck B, O'Sullivan SS, Vincent MB, Rosso AL et al
Neuropsychologia 85:19–23 · 2016 Parkinson's Disease
Apomorphine: A potential modifier of amyloid deposition in Parkinson's disease?
Yarnall AJ, Lashley T, Ling H, Lees AJ, Coleman SY, O'Sullivan SS et al
Movement Disorders 31(5):668–675 · 2016 Parkinson's Disease
Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy
Lesage S, Drouet V, Majounie E, Deramecourt V, Jacoupy M, Nicolas A, O'Sullivan SS et al
American Journal of Human Genetics 98(3):500–513 · 2016 Parkinson's Disease
Morphometric changes in the reward system of Parkinson's disease patients with impulse control disorders
Pellicano C, Niccolini F, Wu K, O'Sullivan SS, Lawrence AD, Lees AJ et al
Journal of Neurology 262(12):2653–2661 · 2016 Parkinson's Disease
Psychogenic and neural visual-cue response in PD dopamine dysregulation syndrome
Loane C, Wu K, O'Sullivan SS, Lawrence AD, Woodhead Z, Lees AJ et al
Parkinsonism & Related Disorders 21(11):1336–1341 · 2015 Parkinson's Disease
Severe Headache With Left Nasal Discharge: Is it Always Due to Autonomic Over Activity?
Bhattacharjee S, Elkider M, O'Sullivan S
Headache · 2015 Headache
Rodent models of impulsive-compulsive behaviors in Parkinson's disease: How far have we reached?
Cenci MA, Francardo V, O'Sullivan SS, Lindgren HS
Neurobiology of Disease 82:561–573 · 2015 Parkinson's Disease
Single versus multiple impulse control disorders in Parkinson's disease: an 11C-raclopride PET study
Wu K, Politis M, O'Sullivan SS, Lawrence AD, Warsi S, Bose S, Lees AJ et al
Journal of Neurology 262(6):1504–1514 · 2015 Parkinson's Disease
Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias
Cheshire P, Ayton S, Bertram KL, Ling H, Li A, McLean C, Halliday GM, O'Sullivan SS et al
Movement Disorders 30(6):796–804 · 2015 Parkinson's Disease
Influence of single nucleotide polymorphisms in COMT, MAO-A and BDNF genes on dyskinesias and levodopa use in Parkinson's disease
Cheshire P, Bertram K, Ling H, O'Sullivan SS, Halliday G, McLean C et al
Neurodegenerative Diseases 13(1):24–28 · 2015 Parkinson's Disease
Problematic internet use in Parkinson's disease
Wu K, Politis M, O'Sullivan SS, Lawrence AD, Warsi S, Lees A, Piccini P
Parkinsonism & Related Disorders 20(5):482–487 · 2014 Parkinson's Disease
Impulsive and compulsive behaviors in Parkinson's disease
Averbeck BB, O'Sullivan SS, Djamshidian A
Annual Review of Clinical Psychology 10:553–580 · 2014 Parkinson's Disease
Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease
Beilina A, Rudenko IN, Kaganovich A, Civiero L, Chau H, Kalia SK, O'Sullivan SS et al
Proceedings of the National Academy of Sciences 111(7):2626–2631 · 2014 Parkinson's Disease
Perceptual decision-making in patients with Parkinson's disease
Djamshidian A, O'Sullivan SS, Lawrence AD, Foltynie T, Aviles-Olmos I et al
Journal of Psychopharmacology 28(12):1149–1154 · 2014 Parkinson's Disease
In a rush to decide: deep brain stimulation and dopamine agonist therapy in Parkinson's disease
Djamshidian A, O'Sullivan SS, Tomassini A, Foltynie T, Limousin P et al
Journal of Parkinson's Disease 4(4):579–583 · 2014 Parkinson's Disease
Impulsive-compulsive behaviours in Parkinson's disease — prevention is better than cure
Ryan SA, O'Sullivan SS
Irish Medical Journal 106(6):162 · 2013 Parkinson's Disease
The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism
Klebe S, Golmard JL, Nalls MA, Saad M, Singleton AB, Bras JM, Hardy J, O'Sullivan SS et al
Journal of Neurology Neurosurgery & Psychiatry 84(6):666–673 · 2013 Parkinson's Disease
The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy
Massey LA, Jäger HR, Paviour DC, O'Sullivan SS, Ling H, Williams DR et al
Neurology 80(20):1856–1861 · 2013 Neurology
Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson's disease
Djamshidian A, O'Sullivan SS, Foltynie T, Aviles-Olmos I, Limousin P et al
Journal of Parkinson's Disease 3(2):139–144 · 2013 Parkinson's Disease
MM2 subtype of sporadic Creutzfeldt-Jakob disease may underlie the clinical presentation of progressive supranuclear palsy
Petrovic IN, Martin-Bastida A, Massey L, Ling H, O'Sullivan SS et al
Journal of Neurology 260(4):1031–1036 · 2013 Neurology
Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers
Okai D, Askey-Jones S, Samuel M, O'Sullivan SS, Chaudhuri KR et al
Neurology 80(9):792–799 · 2013 Parkinson's Disease
Recognition of psychogenic non-epileptic seizures: a curable neurophobia?
O'Sullivan SS, Redwood RI, Hunt D, McMahon EM, O'Sullivan S
Journal of Neurology Neurosurgery & Psychiatry 84(2):228–231 · 2013 Epilepsy / PNES
Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson's disease
Politis M, Loane C, Wu K, O'Sullivan SS, Woodhead Z, Kiferle L et al
Brain 136(2):400–411 · 2013 Parkinson's Disease
Increased reflection impulsivity in patients with ephedrone-induced Parkinsonism
Djamshidian A, Sanotsky Y, Matviyenko Y, O'Sullivan SS, Sharman S et al
Addiction 108(4):771–779 · 2013 Parkinson's Disease
Uncertainty about mapping future actions into rewards may underlie performance on multiple measures of impulsivity in behavioral addiction: evidence from Parkinson's disease
Averbeck BB, Djamshidian A, O'Sullivan SS, Housden CR, Roiser JP et al
Behavioral Neuroscience 127(2):245 · 2013 Parkinson's Disease
Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy
Massey LA, Micallef C, Paviour DC, O'Sullivan SS, Ling H, Williams DR et al
Movement Disorders 27(14):1754–1762 · 2012 Neurology
Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions?
Djamshidian A, O'Sullivan SS, Sanotsky Y, Sharman S, Matviyenko Y et al
Movement Disorders 27(9):1137–1145 · 2012 Parkinson's Disease
Effects of dopamine on sensitivity to social bias in Parkinson's disease
Djamshidian A, O'Sullivan SS, Lees A, Averbeck BB
PLoS One 7(3):e32889 · 2012 Parkinson's Disease
Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours
O'Sullivan SS, Wu K, Politis M, Lawrence AD, Evans AH, Bose SK et al
Brain 134(4):969–978 · 2011 Parkinson's Disease
Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
Compta Y, Parkkinen L, O'Sullivan SS, Vandrovcova J, Holton JL et al
Brain 134(5):1493–1505 · 2011 Parkinson's Disease
Testing an aetiological model of visual hallucinations in Parkinson's disease
Gallagher DA, Parkkinen L, O'Sullivan SS, Spratt A, Shah A, Davey CC et al
Brain 134(11):3299–3309 · 2011 Parkinson's Disease
Does levodopa accelerate the pathologic process in Parkinson disease brain?
Parkkinen L, O'Sullivan SS, Kuoppamäki M, Collins C, Kallis C, Holton JL, Lees AJ et al
Neurology 77(15):1420–1426 · 2011 Parkinson's Disease
Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain
Ohlin KE, Francardo V, Lindgren HS, Sillivan SE, O'Sullivan SS et al
Brain 134(8):2339–2357 · 2011 Parkinson's Disease
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
Höglinger GU, Melhem NM, Dickson DW, Sleiman PMA, Wang LS, Klei L, O'Sullivan SS et al
Nature Genetics 43(7):699–705 · 2011 Neurology
A two-stage meta-analysis identifies several new loci for Parkinson's disease
International Parkinson's Disease Genomics Consortium (incl. O'Sullivan SS)
PLoS Genetics 7(6):e1002142 · 2011 Parkinson's Disease
Sleep disturbance and impulsive-compulsive behaviours in Parkinson's disease
O'Sullivan SS, Loane CM, Lawrence AD, Evans AH, Piccini P, Lees AJ
Journal of Neurology Neurosurgery & Psychiatry 82(6):620–622 · 2011 Parkinson's Disease
Novelty seeking behaviour in Parkinson's disease
Djamshidian A, O'Sullivan SS, Wittmann BC, Lees AJ, Averbeck BB
Neuropsychologia 49(9):2483–2488 · 2011 Parkinson's Disease
Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour
Djamshidian A, O'Sullivan SS, Papadopoulos A, Bassett P, Shaw K et al
Journal of Neurology Neurosurgery & Psychiatry 82(10):1107–1111 · 2011 Parkinson's Disease
Globular glial tauopathies presenting with motor neuron disease or frontotemporal dementia
Ahmed Z, Doherty KM, Silveira-Moriyama L, Bandopadhyay R, Lashley T, O'Sullivan SS et al
Acta Neuropathologica 122(4):415–428 · 2011 Neurology
Putaminal upregulation of FosB/ΔFosB-like immunoreactivity in Parkinson's disease patients with dyskinesia
Lindgren HS, Rylander D, Iderberg H, Andersson M, O'Sullivan SS, Lees AJ et al
Journal of Parkinson's Disease 1(4):347–357 · 2011 Parkinson's Disease
Glucocerebrosidase mutations do not cause increased Lewy body pathology in Parkinson's disease
Parkkinen L, Neumann J, O'Sullivan SS, Holton JL, Revesz T, Hardy J et al
Molecular Genetics and Metabolism 103(4):410–412 · 2011 Parkinson's Disease
The effect of drug treatment on neurogenesis in Parkinson's disease
O'Sullivan SS, Johnson M, Williams DR, Revesz T, Holton JL, Lees AJ et al
Movement Disorders 26(1):45–50 · 2011 Parkinson's Disease
Stroop test performance in impulsive and non impulsive patients with Parkinson's disease
Djamshidian A, O'Sullivan SS, Lees A, Averbeck BB
Parkinsonism & Related Disorders 17(3):212–214 · 2011 Parkinson's Disease
Altruistic punishment in patients with Parkinson's disease with and without impulsive behaviour
Djamshidian A, O'Sullivan SS, Doherty K, Lees AJ, Averbeck BB
Neuropsychologia 49(1):103–107 · 2011 Parkinson's Disease
Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson's disease
Parkkinen L, O'Sullivan SS, Collins C, Petrie A, Holton JL, Revesz T et al
Journal of Parkinson's Disease 1(3):277–286 · 2011 Parkinson's Disease
Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia
Rylander D, Parent M, O'Sullivan SS, Dovero S, Lees AJ, Bezard E et al
Annals of Neurology 68(5):619–628 · 2011 Parkinson's Disease
Does corticobasal degeneration exist? A clinicopathological re-evaluation
Ling H, O'Sullivan SS, Holton JL, Revesz T, Massey LA, Williams DR, Lees AJ
Brain 133(7):2045–2057 · 2010 Neurology
Excessive hoarding in Parkinson's disease
O'Sullivan SS, Djamshidian A, Evans AH, Loane CM, Lees AJ et al
Movement Disorders 25(8):1026–1033 · 2010 Parkinson's Disease
Relationships between age and late progression of Parkinson's disease: a clinico-pathological study
Kempster PA, O'Sullivan SS, Holton JL, Revesz T, Lees AJ
Brain 133(6):1755–1762 · 2010 Parkinson's Disease
Reckless generosity in Parkinson's disease
O'Sullivan SS, Evans AH, Quinn NP, Lawrence AD, Lees AJ
Movement Disorders 25(2):221–223 · 2010 Parkinson's Disease
Impulsive-compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy
O'Sullivan SS, Djamshidian A, Ahmed Z, Evans AH, Lawrence AD et al
Movement Disorders 25(5):638–642 · 2010 Parkinson's Disease
Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease
Djamshidian A, Jha A, O'Sullivan SS, Silveira-Moriyama L, Jacobson C et al
Movement Disorders 25(13):2203–2210 · 2010 Parkinson's Disease
Intact reward learning but elevated delay discounting in Parkinson's disease patients with impulsive-compulsive spectrum behaviours
Housden CR, O'Sullivan SS, Joyce EM, Lees AJ, Roiser JP
Neuropsychopharmacology 35(11):2155–2164 · 2010 Parkinson's Disease
Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia
Rohrer JD, Paviour D, Bronstein AM, O'Sullivan SS, Lees A, Warren JD
Movement Disorders 25(2):179–188 · 2010 Neurology
Concomitant progressive supranuclear palsy and multiple system atrophy
Silveira-Moriyama L, González AM, O'Sullivan SS, Williams DR, Massey L et al
Neuroscience Letters 467(3):208–211 · 2010 Neurology
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
Neumann J, Bras J, Deas E, O'Sullivan SS, Parkkinen L, Lachmann RH et al
Brain 132(7):1783–1794 · 2009 Parkinson's Disease
Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease
Lim SY, O'Sullivan SS, Kotschet K, Gallagher DA, Lacey C, Lawrence AD et al
Journal of Clinical Neuroscience 16(9):1148–1152 · 2009 Parkinson's Disease
Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management
O'Sullivan SS, Evans AH, Lees AJ
CNS Drugs 23(2):157–170 · 2009 Parkinson's Disease
Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression
Song YJC, Halliday GM, Holton JL, Lashley T, O'Sullivan SS et al
Journal of Neuropathology & Experimental Neurology 68(10):1073–1083 · 2009 Neurology
Normal dopamine transporter single photon-emission CT scan in corticobasal degeneration
O'Sullivan SS, Burn DJ, Holton JL, Lees AJ
Movement Disorders 23(16):2410–2411 · 2009 Neurology
A rare cause of fatal intracranial haemorrhage
Neligan A, Mullins GM, O'Sullivan SS, Fitzgerald P, Harrington H
Irish Journal of Medical Science 178(3):343–345 · 2009 Neurology
Clinical outcomes of progressive supranuclear palsy and multiple system atrophy
O'Sullivan SS, Massey LA, Williams DR, Silveira-Moriyama L et al
Brain 131(5):1362–1372 · 2008 Neurology
Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study
O'Sullivan SS, Williams DR, Gallagher DA, Massey LA, Silveira-Moriyama L, Lees AJ
Movement Disorders 23(1):101–106 · 2008 Parkinson's Disease
Parkinson's disease with Onuf's nucleus involvement mimicking multiple system atrophy
O'Sullivan SS, Holton JL, Massey LA, Williams DR, Revesz T, Lees AJ
Journal of Neurology Neurosurgery & Psychiatry 79(2):232–234 · 2008 Parkinson's Disease
Cortical α-synuclein load is associated with amyloid-β plaque burden in a subset of Parkinson's disease patients
Lashley T, Holton JL, Gray E, Kirkham K, O'Sullivan SS, Hilbig A et al
Acta Neuropathologica 115(4):417–425 · 2008 Parkinson's Disease
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, Bressman S et al
The Lancet Neurology 7(7):583–590 · 2008 Parkinson's Disease
Aetiology and prognosis of encephalopathic patterns on electroencephalogram in a general hospital
O'Sullivan SS, Neligan A, Mullins GM, Daly S, McNamara B, Galvin RJ et al
Journal of Clinical Neuroscience 15(6):637–642 · 2008 Neurology
Punding in Parkinson's disease
O'Sullivan SS, Evans AH, Lees AJ
Practical Neurology 7(6):397–399 · 2008 Parkinson's Disease
Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation
Gallagher DA, O'Sullivan SS, Evans AH, Lees AJ, Schrag A
Movement Disorders 22(12):1757–1763 · 2007 Parkinson's Disease
Clinical characteristics and outcome of patients diagnosed with psychogenic nonepileptic seizures: a 5-year review
O'Sullivan SS, Spillane JE, McMahon EM, Sweeney BJ, Galvin RJ et al
Epilepsy & Behavior 11(1):77–84 · 2007 Epilepsy / PNES
Non-traumatic brachial plexopathies, clinical, radiological and neurophysiological findings from a tertiary centre
Mullins GM, O'Sullivan SS, Neligan A, Daly S, Galvin RJ, Sweeney BJ et al
Clinical Neurology and Neurosurgery 109(8):661–666 · 2007 Neurology
Aseptic meningitis: a 2-year review of diagnoses reached in a tertiary neurological and infectious disease centre
O'Sullivan SS, O'Connell B, Redmond J
Irish Journal of Medical Science 176(3):215–219 · 2007 Neurology
Pathological gambling in Parkinson's disease
O'Sullivan SS, Lees AJ
The Lancet Neurology 6(5):384–386 · 2007 Parkinson's Disease
Acquired generalised neuromyotonia, cutaneous lupus erythematosus and alopecia areata in a patient with myasthenia gravis
O'Sullivan SS, Mullins GM, Neligan A, McNamara B, Galvin RJ
Clinical Neurology and Neurosurgery 109(4):374–375 · 2007 Neurology
A study of idiopathic generalised epilepsy in an Irish population
Mullins GM, O'Sullivan SS, Neligan A, McCarthy A, McNamara B et al
Seizure 16(3):204–210 · 2007 Epilepsy / PNES
Detection rates of sexual dysfunction amongst patients with multiple sclerosis in an outpatient setting
O'Sullivan SS, Hardiman O
Irish Medical Journal 99(10):304–306 · 2006 Neurology
The role of the standard EEG in clinical psychiatry
O'Sullivan SS, Mullins GM, Cassidy EM, McNamara B
Human Psychopharmacology: Clinical and Experimental 21(4):265–271 · 2006 Neurology
Late-onset ophthalmoplegic migraine in a patient with previous childhood abdominal migraine
O'Sullivan SS, O'Regan KN, Tormey P, Galvin RJ
Cephalalgia 26(8):1033–1035 · 2006 Headache
The opinion of the general practitioner toward clinical management of patients with psychogenic nonepileptic seizures
O'Sullivan SS, Sweeney BJ, McNamara B
Epilepsy & Behavior 8(1):256–260 · 2006 Epilepsy / PNES
Panniculitis and lipoatrophy after subcutaneous injection of interferon β-1b in a patient with multiple sclerosis
O'Sullivan SS, Cronin EM, Sweeney BJ, Bourke JF, Fitzgibbon J
Journal of Neurology Neurosurgery & Psychiatry 77(12):1382–1383 · 2006 Neurology
Insulinoma presenting as refractory late-onset epilepsy
O'Sullivan SS, Redmond J
Epilepsia 46(10):1690–1691 · 2006 Epilepsy / PNES

Book Chapters

Chapter 12: Football and Movement Disorders
O'Sullivan SS
In: "Letters for Andrew" eds. Ockelford and Butler. Virginia Keiley Publishing, London · 2008 Movement Disorders
Chapter 19: The Dopamine Dysregulation Syndrome
O'Sullivan SS, Lees AJ
In: "The Non-Motor and Non-Dopaminergic Features of Parkinson's Disease" eds. Olanow, Stocchi and Lang. Blackwell Publishing, Oxford · 2011 Parkinson's Disease
Corticobasal Degeneration
Massey LA, O'Sullivan SS
In: "Imaging in Neurodegenerative Disorders" ed. Saba. Oxford University Press, Oxford · 2014 Neurology
Neuroleptic Malignant Syndrome
Djamshidian A, O'Sullivan SS
In: "Medication-Induced Movement Disorders" ed. Friedman. Cambridge University Press, Cambridge · 2015 Movement Disorders
Private Practice
👤
Practice ManagerPaula McAuliffe
📞
🖷
Fax(021) 601 0070
✉️
EmailPMcAuliffe@bonsecours.ie
Healthmail referrals accepted at this address
🕐
Office HoursMonday – Friday, 9:00am – 5:00pm
📍
AddressSuite 4, Clinic A, The Cork Clinic
Western Road, Cork T12 WNN1

Public pay car park adjacent to the building
Referral Information
📄
Referrals RequiredDr O'Sullivan does not accept self-referrals. Prospective patients must be referred by a healthcare professional — typically a GP or Consultant doctor.
✉️
GP & Consultant ReferralsReferral letters and Healthmail referrals may be sent directly to Paula McAuliffe at PMcAuliffe@bonsecours.ie.
⚠️ Medical Emergency

If you are experiencing a stroke, seizure, or other acute neurological emergency, call 999 immediately or attend your nearest Emergency Department.

The Cork Clinic

Headache disorders are among the most prevalent and disabling neurological conditions. The Headache Clinic offers evidence-based specialist assessment with personalised treatment plans for patients with persistent or complex headache.

Conditions Treated

🔴
Migraine

Episodic and chronic migraine, with and without aura. Including menstrual migraine, vestibular migraine, and migraine with brainstem aura.

🔵
Cluster Headache

Diagnosis and management of cluster headache and other trigeminal autonomic cephalalgias (TACs), including SUNCT and hemicrania continua.

Tension-Type Headache

Episodic and chronic tension-type headache, including differentiation from secondary and other primary headache disorders.

🟡
Medication Overuse Headache

Assessment and supervised withdrawal for medication-overuse headache (MOH / rebound headache), with preventive therapy initiation.

🟣
New Daily Persistent Headache

Investigation and management of headache that is continuous from onset, including post-COVID and post-traumatic headache.

🟤
Secondary Headache Disorders

Identification and appropriate investigation of headaches arising from intracranial or systemic causes requiring further workup.

What to Expect at Your First Visit

1
Detailed Clinical History

Your consultation begins with a thorough history of your headache — onset, frequency, duration, severity, associated symptoms, and triggers. Keeping a brief headache diary before your appointment is very helpful.

2
Neurological Examination

A full neurological examination is performed as standard. This helps identify or exclude any underlying neurological cause for your headaches.

3
Investigations (if indicated)

Depending on your history and examination, investigations such as brain MRI or blood tests may be arranged. Not all patients require investigation.

4
Diagnosis & Treatment Plan

A diagnosis will be discussed and a personalised treatment plan agreed. This may include lifestyle advice, acute or preventive medications, or procedural treatments.

5
Ongoing Review & GP Communication

Many patients are reviewed at follow-up to assess treatment response. A letter summarising findings and recommendations is sent to your GP after each consultation, and you will also receive a copy of this letter.

Treatments Offered

Acute / Abortive Therapies
Triptans, gepants, and other targeted acute treatments optimised for individual presentation.
Preventive Medications
Beta-blockers, topiramate, amitriptyline, and newer agents including CGRP antagonists.
Botulinum Toxin (BOTOX®)
OnabotulinumtoxinA for chronic migraine — administered per PREEMPT protocol every 12 weeks.
Anti-CGRP Monoclonal Antibodies
Erenumab, fremanezumab, galcanezumab — for eligible patients with chronic or high-frequency episodic migraine.
Lifestyle & Behavioural Strategies
Evidence-based guidance on sleep, hydration, trigger identification, and biobehavioural approaches.
Greater Occipital Nerve Block Injections
The injection of a steroid and anaesthetic into the back of the head, used as an effective treatment for a number of headache disorders.

Frequently Asked Questions

Do I need a GP referral to attend the Headache Clinic?

Dr O'Sullivan does not accept self-referrals. Prospective patients must be referred by a healthcare professional — typically a GP or Consultant doctor.

What should I bring to my first appointment?

Please bring a list of your current medications (including over-the-counter and supplements) and any previous investigation results (MRI scans, blood tests). A completed headache diary — even a simple note of frequency, duration, severity, and associated symptoms — is extremely helpful.

To ensure you get the maximum benefit from your clinical appointment, if possible please complete a registration form, which can be downloaded here.

How long does a first appointment take?

A new appointment will take approximately 30 minutes and a follow-up 10–20 minutes. Please allow adequate time and avoid scheduling commitments immediately afterwards.

Will I need a brain scan?

Not necessarily. Most patients with a long-standing headache history and a normal neurological examination do not require brain imaging. If there are features warranting further investigation, an MRI or CT scan may be arranged and this will be discussed with you at your appointment.

What are the fees for a consultation?

You will receive information regarding the fees along with your appointment letter.

Please remember that seeing a Private Neurologist is a contract between you and that Doctor. If you have private health insurance this may reimburse you for the whole or part of that cost, but ultimately it is the patient who is responsible for the fees in line with the contractual arrangement with that Doctor. Whilst an average time is given for a consultation it may be longer or shorter depending on necessity.

Dr O'Sullivan may also suggest investigations (for example blood tests or scans) and it is difficult to predict these in advance. Normally, your insurance company should meet these costs but these are again your responsibility.

If you have any questions, please call your insurance provider and Dr O'Sullivan's practice manager to discuss prior to consultation.

The links below are provided as a helpful starting point for patients and their families seeking information about neurological conditions. These resources are not a substitute for professional medical advice — please discuss any concerns with your neurologist or GP.

Important: These links are provided for information purposes only. Dr O'Sullivan does not endorse any specific product, treatment, or commercial service featured on third-party websites. If you have concerns about your own condition or treatment, please contact your medical team directly.